Giant café-au-lait macule in neurofibromatosis 1: A type 2 segmental manifestation of neurofibromatosis 1?

Journal of the American Academy of Dermatology

Volumn 58, Issue 3, 2008, Pages 493-497

  Yang, Chao Chun ^a   Happle, Rudolf ^b   Chao, Sheau Chiou ^a   Yu Yun Lee, Julia ^a   Chen, WenChieh ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CAFE AU LAIT SPOT; CASE REPORT; CLINICAL ASSESSMENT; DERMATOME; DNA EXTRACTION; DNA SEQUENCE; EXON; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; NEUROFIBROMATOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN MANIFESTATION;

ADULT; BUTTOCKS; CAFE-AU-LAIT SPOTS; CODON, NONSENSE; EXONS; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENES, NEUROFIBROMATOSIS 1; HUMANS; MUTATION; NEUROFIBROMATOSIS 1; THIGH;

EID: 38949099046     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.03.013     Document Type: Article

References (40)

1. Stumpf D.A., Alksne J.F., Annegers J.F., Brown S.S., Conneally P.M., Housman D., et al. NIH Consensus Development Conference: Neurofibromatosis conference statement. Arch Neurol 45 (1988) 575-578
2. Pivnick E.K., and Riccardi V.M. Neurofibromatoses. In: Freedberg I.M., Eisen A.Z., Wolff K., Austen K.F., Goldsmith L.A., Katz S.I., et al. (Eds). Fitzpatrick's dermatology in general medicine. 6th ed. (2003), McGraw-Hill, New York 1825-1833
3. Riccardi V.M. Von Recklinghausen neurofibromatosis. N Engl J Med 305 (1981) 1617-1627
4. Huson S.M., Harper P.S., and Compston A.S. Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales. Brain 111 (1988) 1355-1381
5. Erdi H., Boyvat A., and Calikoglu E. Giant café au lait spot in a patient with neurofibromatosis. Acta Dermatol Venereol 79 (1999) 496
6. Thappa D.M., Jeevankumar B., and Karthikeyan K. Giant café-au-lait macule in neurofibromatosis type 1. J Dermatol 28 (2001) 60-61
7. Happle R. A rule concerning the segmental manifestation of autosomal dominant skin disorders: review of case reports providing evidence for dichotomous types of severity. Arch Dermatol 133 (1997) 1505-1509
8. Happle R. Loss of heterozygosity in human skin. J Am Acad Dermatol 41 (1999) 143-161
9. Hager C.M., Cohen P.R., and Tschen J.A. Segmental neurofibromatosis: case reports and review. J Am Acad Dermatol 37 (1997) 864-869
10. Chen W., Fan P.C., and Happle R. Partial unilateral lentiginosis with ipsilateral Lisch nodules and axillary freckling. Dermatology 209 (2004) 321-324
11. Trattner A., David M., Hodak E., Ben-David E., and Sandbank M. Segmental neurofibromatosis. J Am Acad Dermatol 23 (1990) 866-869
12. Archer C.B., Glover M., and Atherton D.J. Segmental neurofibromatosis with generalized café au lait spots. Br J Dermatol 119 Suppl 33 (1988) 96-97
13. Itin P.H., and Buechner S.A. Segmental forms of autosomal dominant skin disorders: the puzzle of mosaicism. Am J Med Genet 85 (1999) 351-354
14. Happle R. Large plexiform neurofibromas may be explained as a type 2 segmental manifestation of neurofibromatosis type 1. Am J Med Genet 98 (2001) 363-364
15. Theos A., and Korf B.R. American College of Physicians; American Physiological Society. Pathophysiology of neurofibromatosis type 1. Ann Intern Med 144 (2006) 842-849
16. Alper J.C., and Holmes L.B. The incidence and significance of birthmarks in a cohort of 4641 new-borns. Pediatr Dermatol 1 (1983) 58-68
17. Riccardi V.M. Neurofibromatosis and Albright's syndrome. Dermatol Clin 5 (1987) 193-203
18. Ruggieri M., and Huson S.M. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56 (2000) 1433-1443
19. Oguzkan S., Cinbis M., Ayter S., Anlar B., and Aysun S. Familial segmental neurofibromatosis. J Child Neurol 19 (2004) 392-394
20. Moss C., and Green S.H. What is segmental neurofibromatosis?. Br J Dermatol 130 (1994) 106-110
21. Huson S.M., and Ruggieri M. The neurofibromatoses. In: Harper J., Oranje A., and Prose N. (Eds). Textbook of pediatric dermatology (2006), Blackwell Publishing, Malden, MA 1467-1490
22. Tinschert S., Naumann I., Stegmann E., Buske A., Kaufmann D., Thiel G., et al. Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene. Eur J Hum Genet 8 (2000) 455-459
23. Vandenbroucke I., van Doorn R., Callens T., Cobben J.M., Starink T.M., and Messiaen L. Genetic and clinical mosaicism in a patient with neurofibromatosis type 1. Hum Genet 114 (2004) 284-290
24. Segal R. Segmental neurofibromatosis of the sciatic nerve: case report. Neurosurgery 33 (1993) 948
25. Rubenstein A., Bader J.L., Aron A.A., and Wallace S. Familial transmission of segmental neurofibromatosis. Neurology 33 Suppl 2 (1983) 76
26. Happle R., Fleiner J., and Loskamp U. Kerinokeratosis papulosa with a type 2 segmental manifestation. J Am Acad Dermatol 50 Suppl 5 (2004) S84-S85
27. Happle R. New aspects of cutaneous mosaicism. J Dermatol 29 (2002) 681-692
28. Happle R. Segmental type-2-manifestation autosomal dominanter Hautkrankheiten: Entwicklung eines neuen formalgenetischen Konzeptes. Hautarzt 52 (2001) 283-287
29. Yang K.H., Rhim H., Cho O.K., Ko B.H., Kim Y., Lee H.W., et al. Segmental colonic plexiform neurofibroma in neurofibromatosis type 1. J Comput Assist Tomogr 26 (2002) 129-131
30. Daschner K., Assum G., Eisenbarth I., Krone W., Hoffmeyer S., Wortmann S., et al. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Biochem Biophys Res Commun 234 (1997) 346-350
31. Kluwe L., Friedrich R.E., and Mautner V.F. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas. Cancer Genet Cytogenet 113 (1999) 65-69
32. Rasmussen S.A., Overman J., Thomson S.A., Colman S.D., Abernathy C.R., Trimpert R.E., et al. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosomes Cancer 28 (2000) 425-431
33. Poblete-Gutierrez P., Wiederholt T., Arne K., Jugert F.K., Marquardt Y., Rubben A., et al. Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel geneic concept. J Clin Invest 114 (2004) 1467-1474
34. Mohyuddin A., Neary W.J., Wallace A., Wu C.L., Purcell S., Reid H., et al. Molecular genetic analysis of the NF2 gene in young patients with unilateral schwannomas. J Med Genet 39 (2002) 315-322
35. Leverkus M., Kluwe L., Föll E.M., Becker G., Bröcker E.B., Mautner V.F., et al. Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis?. Br J Dermatol 148 (2003) 804-809
36. Ruggieri M. Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2): no longer neurofibromatosis type 5 (NF5). Am J Med Genet 101 (2001) 178-180
37. Huson S.M., Compston A.S., Clark P., and Harper P.S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26 (1989) 704-711
38. Consoli C., Moss C., Green S., Balderson D., Cooper D.N., and Upadhyaya M. Gonosomal mosaicism for a nonsense mutation (R1947X) in the NF1 gene in segmental neurofibromatosis type 1. J invest Dermatol 125 (2005) 463-466
39. Wu B.L., Boles R.G., Yaari H., Weremowicz S., Schneider G.H., and Korf B.R. Somatic mosaicism for deletion of the entire NF1 gene identified by FISH. Hum Genet 99 (1997) 209-213
40. De Schepper S., Boucneau J.M., Westbroek W., Mommaas M., Onderwater J., Messiaen L., et al. Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes. J Invest Dermatol 126 (2006) 653-659